Characteristics | Number of cases (%) | SLP-2 expression (%) | P value | |
---|---|---|---|---|
Low or no expression | High expression | |||
Age (years) | 0.433 | |||
<45 | 49 (35) | 11 (22.4) | 38 (77.6) | |
≥45 | 91 (65) | 26 (29.7) | 65 (70.3) | |
CA125 level (before surgery) | 0.067 | |||
<500U/ml | 67 (47.9) | 23 (34.3) | 44 (65.7) | |
≥500U/ml | 73 (52.1) | 15 (20.5) | 58 (79.5) | |
Tumour size | 0.501 | |||
<10 cm | 58 (41.4) | 14 (24.1) | 44 (75.8) | |
≥10 cm | 82 (58.6) | 24 (29.3) | 58 (70.7) | |
The volume of ascites | 0.014 | |||
<1000 ml | 100 (71.4) | 33 (33.0) | 67 (67.0) | |
≥1000 ml | 40 (28.6) | 5 (12.5) | 35 (87.5) | |
Peritoneal cytology | 0.001 | |||
Positive | 68 (48.6) | 10 (14.7) | 58 (85.3) | |
Negative | 72 (51.4) | 28 (38.9) | 44 (61.1) | |
Pathological type | 0.064 | |||
Serous | 80 (57.1) | 20 (25.0) | 60 (75.0) | |
Mucinous | 14 (10.0) | 8 (57.1) | 6 (42.9) | |
Poorly differentiated | 36 (25.7) | 8 (22.2) | 28 (77.8) | |
Othersa | 10 (7.1) | 2 (20.0) | 8 (80.0) | |
Grade of differentiation | 0.072 | |||
G1 | 59 (42.1) | 11 (18.6) | 48 (81.4) | |
G2 | 46 (32.9) | 13 (28.3) | 33 (71.7) | |
G3 | 18 (12.9) | 9 (50.0) | 9 (50.0) | |
Unknown | 17 (12.1) | 5 (29.4) | 12 (70.6) | |
FIGO stage | 0.001 | |||
I | 30 (21.4) | 17 (56.7) | 13 (43.3) | |
II+ III + IV | 110 (78.6) | 21 (19.1) | 89 (88.9) | |
Lymph node metastasis | 0.688 | |||
Positive | 21 (15.0) | 7 (33.3) | 14 (66.7) | |
Negative | 23 (16.4) | 5 (21.7) | 18 (78.3) | |
Not do RPLNDb | 96 (68.6) | 26 (27.1) | 70 (72.9) | |
Cytoreductive surgeryc | 0.185 | |||
Optimal | 107 (76.4) | 32 (29.9) | 75 (70.1) | |
Suboptimal | 33 (23.6) | 6 (18.2) | 27 (81.8) |